The US Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc and BioNTech SE for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.
FDA moving to authorize Pfizer booster for 16-, 17-year-olds - report
By REUTERS
05/03/2024 09:20 PM
By REUTERS
05/03/2024 09:16 PM
By REUTERS
05/03/2024 08:47 PM
By REUTERS
05/03/2024 08:31 PM
By REUTERS
05/03/2024 08:04 PM
By REUTERS
05/03/2024 06:34 PM
By REUTERS
05/03/2024 06:11 PM
By REUTERS
05/03/2024 05:17 PM
By REUTERS
05/03/2024 05:15 PM
By REUTERS
05/03/2024 04:46 PM
By REUTERS
05/03/2024 04:17 PM